Top

Reactions Weekly

Published in:

01-02-2023 | Septicemia | Case report

Antineoplastics

Sepsis and pneumonitis: 2 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Moskowitz AJ, et al. HIGH EFFICACY AND DURABILITY OF SECOND-LINE THERAPY WITH PEMBROLIZUMAB, GEMCITABINE, VINORELBINE, AND LIPOSOMAL DOXORUBICIN IN THE PHASE II STUDY FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA. HemaSphere 6 (Suppl. 5): 45-46 abstr. T099, Oct 2022 [abstract]

Title: Antineoplastics
Sepsis and pneumonitis: 2 case reports
Publication date: 01-02-2023
Publisher: Springer International Publishing
Keywords: Septicemia
Septicemia
Hodgkin Lymphoma
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-32987-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Sepsis and pneumonitis: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

COVID-19 vaccine

Metformin

Dexketoprofen/dipyrone

Multiiple drugs

Mycophenolate/prednisone/tacrolimus

Anakinra